1
|
Djukanović R, Roche WR, Wilson JW, Beasley
CR, Twentyman OP, Howarth RH and Holgate ST: Mucosal inflammation
in asthma. Am Rev Respir Dis. 142:434–457. 1990. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lee M, Kim S, Kwon OK, Oh SR, Lee HK and
Ahn K: Anti-inflammatory and anti-asthmatic effects of resveratrol,
a polyphenolic stilbene, in a mouse model of allergic asthma. Int
Immunopharmacol. 9:418–424. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Barnes PJ: Glucocorticosteroids: Current
and future directions. Br J Pharmacol. 163:29–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Barnes PJ: Mechanisms and resistance in
glucocorticoid control of inflammation. J Steroid Biochem Mol Biol.
120:76–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Parikh K, Hall M, Mittal V, Montalbano A,
Gold J, Mahant S, Wilson KM and Shah SS: Comparative effectiveness
of dexamethasone versus prednisone in children hospitalized with
asthma. J Pediatr. 167:639–44 e14. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
van Vollenhoven RF: Treatment of
rheumatoid arthritis: State of the art 2009. Nat Rev Rheumatol.
5:531–541. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Peine KJ, Guerau-de-Arellano M, Lee P,
Kanthamneni N, Severin M, Probst GD, Peng H, Yang Y, Vangundy Z,
Papenfuss TL, et al: Treatment of experimental autoimmune
encephalomyelitis by codelivery of disease associated Peptide and
dexamethasone in acetalated dextran microparticles. Mol Pharm.
11:828–835. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jiang X, Zhao M, Wang Y, Zhu H, Zhao S, Wu
J, Song Y and Peng S: RGD (F/S/V)-Dex: Towards the development of
novel, effective and safe glucocorticoids. Drug Des Devel Ther.
10:1059–1076. 2016.PubMed/NCBI
|
9
|
Ren H, Liang D, Jiang X, Tang J, Cui J,
Wei Q, Zhang S, Yao Z, Shen G and Lin S: Variance of spinal
osteoporosis induced by dexamethasone and methylprednisolone and
its associated mechanism. Steroids. 102:65–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Daull P, Paterson CA, Kuppermann BD and
Garrigue JS: A preliminary evaluation of dexamethasone palmitate
emulsion: A novel intravitreal sustained delivery of corticosteroid
for treatment of macular edema. J Ocul Pharmacol Ther. 29:258–269.
2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Anderson R, Franch A, Castell M,
Perez-Cano FJ, Bräuer R, Pohlers D, Gajda M, Siskos AP, Katsila T,
Tamvakopoulos C, et al: Liposomal encapsulation enhances and
prolongs the anti-inflammatory effects of water-soluble
dexamethasone phosphate in experimental adjuvant arthritis.
Arthritis Res Ther. 12:R1472010. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Nishiwaki S, Nakayama T, Murata M, Nishida
T, Terakura S, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, et
al: Dexamethasone palmitate ameliorates macrophages-rich
graft-versus-host disease by inhibiting macrophage functions. PLoS
One. 9:e962522014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chono S, Tauchi Y and Morimoto K: Aortic
drug delivery of dexamethasone palmitate incorporated into lipid
microspheres and its antiatherosclerotic effect in atherogenic
mice. J Drug Target. 13:407–414. 2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Yang Y, Li H, Gao K, Liu M, Sun Y, Yan T,
Fawcett JP, Cui Y and Gu J: Simultaneous quantitation of
dexamethasone palmitate and dexamethasone in human plasma by liquid
chromatography/tandem mass spectrometry. J Chromatogr B Analyt
Technol Biomed Life Sci. 862:119–124. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Doi T, Ohga S, Ishimura M, Takada H, Ishii
K, Ihara K, Nagai H and Hara T: Long-term liposteroid therapy for
idiopathic pulmonary hemosiderosis. Eur J Pediatr. 172:1475–1481.
2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Janet C: Garber: Guide for The Care
Laboratory Animals. 8th. The National Academics press; Washington,
DC: pp. 1-175.c142011
|
17
|
Otsubo K, Fukumura A, Hirayama M, Morimoto
T, Kato M and Mochizuki H: Hemophagocytic lymphohistiocytosis
caused by systemic herpes simplex virus type 1 infection:
Successful treatment with dexamethasone palmitate. Pediatr Int.
58:390–393. 2016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Nakagishi Y, Shimizu M, Kasai K, Miyoshi M
and Yachie A: Successful therapy of macrophage activation syndrome
with dexamethasone palmitate. Mod Rheumatol. 26:617–620.
2016.PubMed/NCBI
|
19
|
Hoshi K, Mizushima Y, Shiokawa Y, Kageyama
T, Honma M, Kashiwazaki S, Shichikawa K, Tsunematsu T and Kaneko K:
Double-blind study with liposteroid in rheumatoid arthritis. Exp
Clin Res. 11:621–626. 1985.
|
20
|
Jain VV, Kitagaki K, Businga T, Hussain I,
George C, O'shaughnessy P and Kline JN: CpG-oligodeoxynucleotides
inhibit airway remodeling in a murine model of chronic asthma. J
Allergy Clin Immunol. 110:867–872. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Freishtat RJ, Nagaraju K, Jusko W and
Hoffman EP: Glucocorticoid efficacy in asthma: Is improved tissue
remodeling upstream of anti-inflammation. J Investig Med. 58:19–22.
2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Liang Z, Xu Y, Wen X, Nie H, Hu T, Yang X,
Chu X, Yang J, Deng X and He J: Rosmarinic acid attenuates airway
inflammation and hyperresponsiveness in a murine model of asthma.
Molecules. 21:pii: E7692016. View Article : Google Scholar
|
23
|
Deng Y, Chen W, Zang N, Li S, Luo Y, Ni K,
Wang L, Xie X, Liu W, Yang X, et al: The antiasthma effect of
neonatal BCG vaccination does not depend on the Th17/Th1 but
IL-17/IFN-γ balance in a BALB/c mouse asthma model. J Clin Immunol.
31:419–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Huang CQ, Li W, Wu B, Chen WM, Chen LH, Mo
GW, Zhang QF, Gong L, Li J, Zhang HC, et al: Pheretima aspergillum
decoction suppresses inflammation and relieves asthma in a mouse
model of bronchial asthma by NF-κB inhibition. J Ethnopharmacol.
189:22–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kim SG and Lee E, Park NY, Park HH, Jeong
KT, Kim KJ, Lee YJ, Jin M and Lee E: Britanin attenuates
ovalbumin-induced airway inflammation in a murine asthma model.
Arch Pharm Res. 39:1006–1012. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lei W, Zeng DX, Zhu CH, Liu GQ, Zhang XQ,
Wang CG, Wang Q and Huang JA: The upregulated expression of
OX40/OX40L and their promotion of T cells proliferation in the
murine model of asthma. J Thorac Dis. 6:979–987. 2014.PubMed/NCBI
|
27
|
Lee JJ, Dimina D, Macias MP, Ochkur SI,
McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA,
et al: Defining a link with asthma in mice congenitally deficient
in eosinophils. Science. 305:1773–1776. 2004. View Article : Google Scholar : PubMed/NCBI
|
28
|
Humbles AA, Lloyd CM, McMillan SJ, Friend
DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH and
Gerard C: A critical role for eosinophils in allergic airways
remodeling. Science. 305:1776–1779. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhao YT, Zhang XG, Bai L, Li LQ and Yu JE:
Effects of Chinese herbal medicine Pingchuan Formula on airway
inflammation, interferon-γ and interleukin-4 in mice with asthma.
Zhong Xi Yi Jie He Xue Bao. 10:807–813. 2012.(In Chinese).
View Article : Google Scholar : PubMed/NCBI
|
30
|
Liu F, Yu J, Bai L, Xue Z and Zhang X:
Pingchuan formula improves asthma via restoration of the Th17/Treg
balance in a mouse model. BMC Complement Altern Med. 15:2342015.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Hardy R and Cooper MS:
Glucocorticoid-induced osteoporosis-a disorder of mesenchymal
stromal cells? Front Endocrinol (Lausanne). 2:242011.PubMed/NCBI
|
32
|
Zhu FB, Wang JY, Zhang YL, Quan RF, Yue
ZS, Zeng LR, Zheng WJ, Hou Q, Yan SG and Hu YG: Curculigoside
regulates proliferation, differentiation, and pro-inflammatory
cytokines levels in dexamethasone-induced rat calvarial
osteoblasts. Int J Clin Exp Med. 8:123372015.PubMed/NCBI
|
33
|
Weinstein RS: Glucocorticoid-induced
osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am.
41:595–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Weinstein RS: Glucocorticoid-induced
osteonecrosis. Endocrine. 41:183–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
35
|
Bilezikian JP: Combination anabolic and
antiresorptive therapy for osteoporosis: Opening the anabolic
window. Curr Osteoporos Rep. 6:24–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
36
|
Liu C, Janke LJ, Kawedia JD, Ramsey LB,
Cai X, Mattano LA Jr, Boyd KL, Funk AJ and Relling MV: Asparaginase
potentiates glucocorticoid-induced osteonecrosis in a mouse model.
PLoS One. 11:e01514332016. View Article : Google Scholar : PubMed/NCBI
|
37
|
Yoon HY, Cho YS, Jin Q, Kim HG, Woo ER and
Chung YS: Effects of ethyl acetate extract of poncirus trifoliata
fruit for glucocorticoid-induced osteoporosis. Biomol Ther (Seoul).
20:89–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
38
|
Lee DW and Choi EY: A comparative study of
bone mineral density among patients with obstructive lung diseases
in Korea. Int J Tuberc Lung Dis. 19:1246–1251. 2015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Jung JW, Kang HR, Kim JY, Lee SH, Kim SS
and Cho SH: Are asthmatic patients prone to bone loss? Ann Allergy
Asthma Immunol. 112:426–431. 2014. View Article : Google Scholar : PubMed/NCBI
|
40
|
Kim JW, Ku SK, Han MH, Kim KY, Kim SG, Kim
GY, Hwang HJ, Kim BW, Kim CM and Choi YH: The administration of
Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy
in mice. Int J Mol Med. 36:29–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
41
|
Lv Y, Yu J, Sheng Y, Huang M, Kong X, Di
W, Liu J, Zhou H, Liang H and Ding G: Glucocorticoids suppressing
the browning of adipose tissue via miR-19b in male mice.
Endocrinology. Oct 24–2017.(Epub ahead of print).
|
42
|
Massaccesi L, Goi G, Tringali C, Barassi
A, Venerando B and Papini N: Dexamethasone-induced skeletal muscle
atrophy increases O-GlcNAcylation in C2C12 cells. J Cell Biochem.
117:1833–1842. 2016. View Article : Google Scholar : PubMed/NCBI
|
43
|
Mammi CM, Marzolla V, Armani A, Feraco A,
Antelmi A, Maslak E, Chlopicki S, Cinti F, Hunt H, Fabbri A and
Caprio M: A novel combined glucocorticoid-mineralocorticoid
receptor selective modulator markedly prevents weight gain and fat
mass expansion in mice fed a high-fat diet. Int J Obes (Lond).
40:964–972. 2016. View Article : Google Scholar : PubMed/NCBI
|